Phytochemicals: Alternative for Infertility Treatment and Associated Conditions

Chorosho, Saziini H.; Malik, Neha; Panesar, Gulsheen; Kumari, Pratima; Jangra, Sarita; Kaur, Rupinder; Al-Ghamdi, Mariam S.; Albishi, Tasahil S.; Chopra, Hitesh; Singh, Ravinder; Murthy, H. C. Ananda

doi:https://doi.org/10.1155/2023/1327562

Oxidative Medicine and Cellular Longevity

On this page

Abstract Introduction Conclusion Data Availability Conflicts of Interest Authors’ Contributions References Copyright Related Articles

Special Issue

Role of Natural Products in Aging-Associated Diseases

View this Special Issue

Review Article | Open Access

Volume 2023 | Article ID 1327562 | https://doi.org/10.1155/2023/1327562

Phytochemicals: Alternative for Infertility Treatment and Associated Conditions

Saziini H. Chorosho,¹Neha Malik,¹Gulsheen Panesar,¹Pratima Kumari,¹Sarita Jangra,¹Rupinder Kaur,¹Mariam S. Al-Ghamdi,²Tasahil S. Albishi,²Hitesh Chopra,¹Ravinder Singh,¹and H. C. Ananda Murthy^3,4

Academic Editor: Maria Silvana Alves

Received07 Jan 2023

Revised04 Mar 2023

Accepted25 Apr 2023

Published11 May 2023

Abstract

Infertility and obstetric complications have become global health issues in the past few years. Infertility is defined as the inability of a couple to conceive even after twelve months or more of regular and unprotected intercourse. According to WHO data published in the year 2020, 186 million people have infertility globally. Factors leading to infertility are variable in both males and females. But some common factors include smoking, alcohol consumption, obesity, and stress. Various synthetic drugs and treatment options are available that are effective in treating infertility, but their prolonged usage produces various unwanted adverse effects like hot flashes, mood swings, headaches, and weight gain. In extreme cases, these may also lead to the development of anxiety and depression. Herbal remedies have gained a lot of popularity over the years, and people’s inclination toward them has increased all over the world. The prime reason is that these show significant therapeutic efficacy and have fewer side effects. The therapeutic efficacy of plants can be attributed to the presence of diverse phytochemical classes of constituents like alkaloids, flavonoids, and volatile oils. These secondary metabolites, or phytomolecules, can be used to develop herbal formulations. The review highlights the applications and mechanisms of action of various phytochemicals for treating infertility. Also, it focuses on the various future prospects associated with it.

1. Introduction

According to the WHO, infertility is considered a global health concern, affecting millions of people of reproductive age. According to epidemiological studies, approximately 48 million couples and 186 million individuals worldwide are infertile. Infertility can be defined as a condition of the male or female procreative system characterized by the failure to conceive after 12 months of consistent unprotected sexual contact [1]. In males, it can be due to injury of the testicles, varicocele, testicular cancer, hypogonadism, azoospermia, undescended testicles, and premature ejaculation [2, 3]. Additionally, other factors contributing to male infertility include cystic fibrosis, turner syndrome, and fragile X syndrome [2, 4, 5]. In the case of females, the most common risk factors associated with infertility include a history of tubal pregnancy, abnormal menstruation, ovarian disorders, uterine fibroids, intrauterine adhesion, endometriosis, and uterine polyps. It is also observed that women older than 35 experience problems conceiving; thus, an evaluation of infertility can begin after 6 months, while an immediate evaluation is advised if the woman is over 40. Metabolic disorders like polycystic ovary syndrome (PCOS), diabetes mellitus, and obesity also enhance the epidemiology of infertility in affected couples [6, 7]. The schematic flow chart of the factors leading to female infertility is presented in Figure 1.

Furthermore, alcohol consumption, smoking, and toxic environmental exposure like lead and pesticides may enhance the risk of infertility in both sexes [2, 5, 8]. Figure 2 displays the schematic flow chart of the factors leading to male infertility. Over the years, various techniques have been developed through which infertility can be treated in both males and females. For instance, assisted reproductive techniques (ART), intracytoplasmic sperm injection (ICSI), varicocelectomy, and transurethral ejaculatory duct resection (TEDR) are widely used for treating infertility in males, and for females, there are preliminary tubal surgeries, gamete intrafallopian transfer (GIFT), fimbrioplasty, and tubal reanastomosis. Also, intrauterine insemination (IUI) and in vitro fertilization (IVF) are trending treatment options for both female and male infertility [2, 9, 10]. Although these therapies are conventionally used, there are certain limitations too. For example, assisted reproductive techniques (ART) somehow do not assure pregnancy as well as a live birth. Also, the success rate is significantly lower than the failure rate. The mentioned treatments besides being highly expensive and of long duration also impact the mental health of the patients. Infertile couples undergoing such treatments are reported to show high levels of anxiety as well as depression. Literature shows that infertile females face more stress than infertile males because of the social burden of childbearing. Though children conceived through IVF are healthy, IVF is associated with a high risk of perinatal and obstetric results. It may also lead to preterm labor and delivery and underweight babies. It is also related to congenital defects and neurological disorders [11, 12]. Plants and phytochemicals have been used for ages for the treatment of infertility. Numerous plants like Ashoka, Shatavari, Dashmool, and Guduchi have been employed in Ayurveda for treating infertility. Plants are known to treat infertility through diverse mechanisms like improving prematured ovarian failure, improving egg and sperm quality, treating PCOD, and balancing the hormones. A case study published by Asmabi and Jithesh in 2022 showed that treating PCOS through Ayurvedic intervention led to regular ovulation which further led to a healthy pregnancy. Prior to the Ayurvedic intervention, the patient underwent both intrauterine insemination and hormonal therapy for conception, which were unsuccessful. Thus, plants have significant potential to be used for treating infertility and associated conditions. These can be used as such or along with conventional therapies for managing infertility [13, 14]. Besides, the emergent use of plants in treating a number of disease conditions other than infertility has become remarkable. Phytoconstituents such as caflanone present in Cannabis sativa L.; crocin extracted from Crocus sativus L.; quinadoline B found in Cladosporium sp.; delphinidin 3,3-di-glucoside-5-(6-p-coumarylglucoside) (DGCG) isolated from Gentiana cv. Albireo; anethole present in Foeniculum vulgare Mill., Croton grewioides Baill., etc.; curcumin found in Curcuma longa L.; and adlumidine present in Fumaria indica have proven effective in tackling the recent COVID-19 outbreak [15]. The recent trends of the application of phyto-nanotechnology in treating neurological disorders (ND) such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) have proven their significance. The various phytoconstituents incorporated in this application are α- and β-asarone found in Acorus calamus; S-allyl cysteine (SAC) found in Allium sativum; curcumin found in Curcuma longa; quercetin 3-glucuronide, glycitin, caffeic acid, and protocatechinic acid found in Coriandrum sativum L.; hyperoside found in Hypericum perforatum; etc. [16]. A natural polyphenolic compound, resveratrol, has gained its popularity in treating not only infertility but also a number of disease conditions by acting as an antioxidant, anticancer, cardioprotective, and anti-inflammatory [17]. Another natural phenolic compound, curcumin, found in the Curcuma genus can be formulated for effective drug delivery. It has been useful in treating skin disorders, cancers, neurological disorders, inflammation, multiple myeloma, etc. [18]. This article emphasizes the use of phytochemicals for the treatment of infertility and associated conditions. Table 1 provides a summary of different herbal plants and the parts of those plants that are used to treat infertility and other related conditions.

2. Mechanism of Action of Selected Plant Constituents for Treating Infertility and Associated Conditions

2.1. Resveratrol’s Role in the Anti-Inflammatory Process in Endometriosis

Resveratrol (trans-3,5,40-trihydroxystilbene) is a naturally occurring polyphenolic compound found in berries, wine, peanuts, grapes, soy, etc. It is also found in plants such as Veratrum grandiflorum and Polygonum cuspidatum. It possesses antiatherogenic, antiproliferative, antineoplastic, anti-inflammatory, antiangiogenic, and antineoplastic properties. This compound (Figure 3) works by reducing the cases of endometriosis in females by inhibiting prostaglandin synthesis, a significant anti-inflammatory effect of resveratrol.

Battaglia et al. in 2022 showed that resveratrol enhances the biogenesis in granulosa cells, which in turn improves folliculogenesis. This was done by modifying the miRNome which acts on miRNA involved in the mitochondrial pathway. This led to the quality enhancement of oocytes resulting in better chances of pregnancy [92].

A different study conducted by Illiano et al. in 2020 showed that resveratrol supplements enhanced the concentration of sperm as well as their motility in idiopathic infertility of males [93]. Resveratrol is known to improve the ovarian function by promoting the expression of sirtuin (SIRT) 1 expression in the ovaries. Upregulation of SIRT 1 expression reduces the oxidative stress leading to enhanced telomerase activity which is associated with better ovarian function. Resveratrol also inhibits the aging of endometrial cells which is important for the implantation of an embryo. This is because resveratrol inhibits the expression of CRABP 2-RAR [94]. Thus, resveratrol serves as a potential therapeutic molecule for the management of infertility as well as other disorders associated to it.

Rudzitis-Auth et al., in 2013, experimented on twenty female mice and surgically induced endometriosis by transplanting uterine tissue into the abdominal cavity. This resulted in mesenteric and peritoneal endometriotic lesions. Resveratrol, when administered with a dose of 40 mg/kg/day by oral gavage for a duration of 4 weeks, resulted in the inhibition of angiogenesis in mesenteric and peritoneal endometriotic lesions [95].

Resveratrol exerts varying effects on a number of molecular pathways mainly involved in inflammation, namely, the Ah (aryl hydrocarbon) receptor, Nf-ĸB (nuclear factor kappa-light-chain-enhancer of activated B cells), arachidonic acid, or AP-1 (activator protein-1).

2.1.1. Arachidonic Acid Pathway

Resveratrol interacts with COX-2 (cyclooxygenase-2) in this pathway by suppressing its effects at various stages. A study revealed that resveratrol in the epithelial cells of mammary glands suppresses PMA- (phorbol 12-myristate 13-acetate-) induced cyclooxygenase transcription by mainly inhibiting the protein kinase C pathway and eventually inhibiting inflammation. Moreover, resveratrol also works by preventing the induction of COX-2 (cyclooxygenase-2) promoter activity, which is mediated by c-Jun and ERK-1 (extracellular signal-regulated kinase-1).

2.1.2. Aryl Hydrocarbon Receptor (AhR)

This receptor plays a key role in the immune system as it is a mediator of dioxin toxicity, and dioxin induces immunosuppression. A study concluded that AhR (aryl hydrocarbon receptor) binds to different factors such as Nf-ĸB (nuclear factor kappa-light-chain-enhancer of activated B cells), estrogen receptors, and E2F1. Resveratrol has been identified as producing antagonistic effects on AhR (aryl hydrocarbon receptor). The immune system is regulated by the effector Th17 (T helper 17) subset and FoxP3+ (forkhead box P3) Tregs (regulatory T cells). Different studies revealed that resveratrol could inhibit Th17 (T helper 17) cell and FoxP3+ (forkhead box P3) Treg (regulatory T cell) development. Researchers concluded that resveratrol has a positive outcome in controlling inflammation by inhibiting Th17 (T helper 17) cells.

2.1.3. Activator Protein-1 Pathway

Activator protein-1, together with NFAT (nuclear factor of activated T cells), STATs (signal transducer and activator of transcription proteins), and Nf-ĸB (nuclear factor kappa-light-chain-enhancer of activated B cells), is involved in initiating the inflammatory process. This inflammatory process involves enhancing the transcription of several biomolecules as well as proinflammatory cytokines. AP-1 (activator protein-1) activation is induced by multiple cytokines, mainly by MAPK (mitogen-activated protein kinase) and JNK (c-Jun N-terminal kinase) signaling, cellular stress, growth factors, and hormones. AP-1 (activator protein-1) proteins, when activated, have a major function in T cell differentiation, which causes various inflammatory conditions. Different studies also suggested that this compound inhibits COX-2 (cyclooxygenase-2) activity indirectly by primarily inhibiting the AP-1 (activator protein-1) pathways, interfering with the inflammatory process.

2.1.4. Nf-ĸB (Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells) Pathway

The Nf-ĸB (nuclear factor kappa-light-chain-enhancer of activated B cells) proteins are activated by the phosphorylation of IĸB (inhibitor of ĸB) proteins. When activated, it activates several target genes, which are responsible for inflammatory responses and cell proliferation. A study suggested that resveratrol suppresses Nf-ĸB (nuclear factor kappa-light-chain-enhancer of activated B cells) activation by blocking TNF-α (tumor necrosis factor-alpha) and inducing the activation of Nf-ĸB (nuclear factor kappa-light-chain-enhancer of activated B cells). Different researchers also proved that resveratrol prevents the Nf-ĸB (nuclear factor kappa-light-chain-enhancer of activated B cells) activation through various stimuli other than TNF-α (tumor necrosis factor-alpha) like okadaic acid, H₂O₂ (hydrogen peroxide), and other proinflammatory cytokines, for instances, LPS (lipopolysaccharide) or IL-1β (interleukin-1 beta) [96].

2.2. Phytoestrogens in Male Reproductive System

These are naturally occurring nonsteroidal compounds present in many medicinal plants such as Nigella sativa, Punica granatum, and Glycyrrhiza glabra. Phytoestrogens include various categories, namely, lignans, still beans, flavones, and coumestans. These have become popular as abundant literature is available regarding their adverse effects, and also, people are shifting toward plant-derived proteins (soya) which are rich in phytoestrogens [97]. They bind to ERα (estrogen receptor alpha) and ERβ (estrogen receptor beta) by mimicking estradiol’s conformational structure. They act on the male reproductive system by interacting with the estrogen receptors and by another mechanism, behaving as an antioxidant or tyrosine kinase inhibitor. It also interferes with the androgen receptor pathway and affects spermatogenesis in males [98].

Cooper and Amber in 2019 reported that phytoestrogens such as soy isoflavones exhibit a similar chemical structure to 17β-estradiol. The two major soy isoflavones, namely, daidzein and genistein, bind to estrogen receptor beta (ERβ), suggesting beneficial effects on fertility, although they are weak estrogens in comparison to endogenous E₂. The soy isoflavones act by two pathways, namely, the hormonal and nonhormonal pathways, that involve the arrest or alteration of cellular growth through tyrosine kinase or epigenetics [99].

A different study by Desmawati and Sulastri in 2019 revealed the importance of phytoestrogen and genistein (Figure 4) on female fertility. It acts by stimulating progesterone hormone stimulation in the ovaries, estradiol, and cAMP production, maturation of oocytes, and development of zygote in the preimplantation stage of women [100].

2.3. Eugenol on Stress-Induced Female Reproductive Dysfunction

Eugenol (Figure 5) is a natural phenolic compound (1-allyl-4-hydroxy-3-methoxybenzene) widely present in medicinal plants, namely, Cinnamomum verum (cinnamon), Myristica fragrans (nutmeg), and Ocimum basilicum (basil). It possesses antioxidant, antipyretic, anti-inflammatory, and analgesic properties. In addition, it also has antidepressant properties.

Nikbin et al. in 2020, in their study, showed that eugenol supplements when given with exercise training work by improving the destructive effects of CPF (chlorpyrifos) on testicular tissue at the cellular level, by enhancing PLZF (promyelocytic leukemia zinc finger) and IGFα (insulin-like growth factor α). This improves the anatomy of the testis, thereby increasing spermatogenesis in males [101].

Stress is a major concern in the present society, affecting all age groups. Females are found to be more susceptible to reproductive disorders related to stress in comparison to males. Chronic stress has a huge impact on sexual dysfunction. It has also shown negative outcomes for subjects who are on infertility treatment. Changes in the reproductive hormonal levels in females have been reported, leading to ovulation disorders and infertility.

In CUMS (chronic unpredictable mild stress), there is a significant elevation of serum cortisol. It is regarded as a major index for triggering stress responses in humans. Chronic stress results in the activation of the HPA (hypothalamic-pituitary-adrenal) axis due to the induction of the hypothalamic release of CRH (corticotropin-releasing hormone), further activating CRHR-1 (corticotropin-releasing hormone receptor-1). Activation of CRHR-1 (corticotropin-releasing hormone receptor-1) stimulates and releases ACTH (adrenocorticotropic hormone) by acting on the adrenal cortex. It further stimulates and produces the hormone cortisol. At a certain level, cortisol helps in the regulation of metabolism and self-maintenance by coping with stressors. But, in constant and prolonged stressful situations, the negative outcome of the HPA (hypothalamic-pituitary-adrenal) axis is impaired. This further leads to the continuous release of serum cortisol. Elevated serum cortisol levels have negative effects such as immune system suppression, cognitive dysfunction, metabolic disturbances, and reproductive functions. In females, the CRHR (corticotropin-releasing hormone receptor) is present in the ovaries and uterus; therefore, it has a role in regulating follicular development and ovarian functions. An elevation in the genetic expression of CRHR-1 (corticotropin-releasing hormone receptor-1) is observed in the ovarian tissues of females induced by stress. In females under prolonged stress, the exaggerated CRH (corticotropin-releasing hormone) effects could further cause inhibition of ovarian steroidogenesis, ovarian failure, and follicular atresia. Eugenol has been shown in studies to interfere with the stress-activated hypothalamic-pituitary-adrenal axis, resulting in a decrease in serum cortisol. Moreover, the HPA (hypothalamic-pituitary-adrenal) axis deactivation concludes the decline of stress-associated overexpression of CRHR-1 (corticotropin-releasing hormone receptor-1). Hence, it can be concluded that eugenol administration could have a positive impact on females struggling with stress-induced reproductive disorders, thereby affecting fertility [102].

2.4. Effect of Apigenin on Polycystic Ovary Syndrome

Apigenin is an active flavonoid that is found in dietary products like parsley, oranges, chamomile tea, celery, or wheat. Chemically, apigenin is referred to as 4, 5, and 7-trihydroxy flavone. Its chemical formula is C₁₅H₁₀O₅ (Figure 6).

In PCOS (polycystic ovary syndrome), a decrease in the number of antral follicles, preantral, granulosa layer thickness, and corpora lutea and an enlargement in theca layer thickness and cystic follicles occur. These changes are caused by an increase in oxidative stress and thus a lack of ovulation. Apigenin significantly inhibits oxidative stress as well as decreases the levels of estradiol and thus significantly enhances the count of corpora lutea and primary and graafian follicles and reduces the count of atretic and cystic follicles. Also, it reduces the theca thickness and increases the thickening of the granulosa layer, thus helping in follicular and ovulation development as there is an increase in normal corpora lutea and normal follicles [103].

Peng et al. experimented on female Sprague-Dawley rats and injected them subcutaneously with DHEA (dehydroepiandrosterone) at a dose concentration of 60 mg/kg for 20 days to induce PCOS (polycystic ovary syndrome). This resulted in a rise in ovarian diameter, body weight, and cysts in the rats. Apigenin with a dose concentration of 20 mg/kg was given by oral gavage to treat PCOS (polycystic ovary syndrome). This resulted in an improved antioxidant status and lipid profile. Also, body weight, ovarian diameter, and cysts were normalized, and healthy follicles were restored [104].

A different study by Park et al. in 2017 reported the antiproliferative as well as apoptotic effects of a plant-derived flavonoid, apigenin, on endometriosis cell lines VK2/E6E7 and End1/E6E7. Apigenin reduces DNA replication and induces cell cycle arrest as well as DNA fragmentation eventually resulting in apoptosis in both the endometriosis cell lines. This process is mediated via the mitochondrial-dependent pathways through the induction of depolarization of ROS (reactive oxygen species) generation, calcium efflux, MMP (mitochondrial membrane potential), and proapoptotic proteins. It also works by inducing ER (endoplasmic reticulum) stress by activating UPR (unfolded protein response) genes. Their apoptotic effects were mediated through the AKT and MAPK (mitogen-activated protein kinase) signal transduction pathways. Hence, apigenin could be considered a novel therapeutic agent in treating endometriosis by activating the integrated intracellular signaling pathways [105].

2.5. Effect of Protodioscin in Male Infertility and Impotence

Protodioscin is an active compound that is extracted from the leaves of the plant Tribulus terrestris. This plant belongs to the family Zygophyllaceae. This compound is categorized as furostanol saponins (Figure 7). It is available under the brand name Libilov™. Over the years, this herb is used to treat male infertility as well as impotence in European and Asian countries [106].

Protodioscin works in the body by activating an enzyme, 5-alpha reductase. This enzyme enhances the production of the hormone testosterone and converts the testosterone into the hormone dihydrotestosterone. Testosterone activates the Sertoli as well as the geminal cells, which leads to more sperm production and spermatogenesis. While dihydrotestosterone works in the Sertoli cells by stimulating the formation of ABP (androgen-binding protein), this leads to the formation of the DHT–ABP (dihydrotestosterone–androgen-binding protein) complex, which enhances spermatozoa’s ability to mature into fertile sperm. Moreover, DHT (dihydrotestosterone) stimulates muscle development and helps in the RBC (red blood cell) formation. This RBC formation increases the level of haemoglobin and thus regulates the oxygen transport system as well as the circulation of blood, eventually causing libido [107].

Arsyad experimented on males with oligozoospermia. They treated them with tablets of Libilov, an extract of Tribulus terrestris containing an active ingredient, protodioscin, with a dose of to tablets per day for 14 to 60 days. This resulted in improved quality and concentration of spermatozoa. It also showed an improvement in orgasm, ejaculation, erection, germinal cells, Sertoli cells, and sexual libido. Moreover, there was an enhancement in the efficiency of the conversion of the hormone testosterone to dihydrotestosterone [107].

A different study by Salgado et al. in 2017 outlined that the main phytoconstituent of the Tribulus genus, protodioscin, enhances the chances of fertility in the male by acting on the Sertoli cells, in the seminiferous tubule growth. It converts the hormone testosterone into dihydrotestosterone, thereby playing a major role in male attributes. It also increases serum dehydroepiandrostenedione (DHEA) concentrations resulting in an increase in erectile function [58].

2.6. Eurycomanone for Enhancing Male Infertility

Eurycomanone (Figure 8) is an active quassinoid that is extracted from the roots of Eurycoma longifolia, belonging to the family Simaroubaceae. It is commonly called tongkat ali. Chemically, this is written as C₂₀H₂₄O₉. This plant is premixed in several beverages and for ages, used in treating male infertility. This quassinoid inhibits two enzymes, phosphodiesterase and aromatase, that are responsible for the synthesis of estradiol.

Due to the reduction of estradiol, there is an increase in the stimulation of the hypothalamus resulting in the secretion of two gonadotropins, the FSH (follicle-stimulating hormone) and the LH (luteinizing hormone). The FSH (follicle-stimulating hormone) and LH (luteinizing hormone) influence the production of testosterone in the Leydig cells. Testosterone along with the FSH (follicle-stimulating hormone) is responsible for regulating spermiogenesis in the seminiferous tubules and thus helps in enhancing fertility in men [108].

In a study by Low et al. in 2013, the major quassinoid, eurycomanone, found in Eurycoma longifolia inhibits aromatase conversion of the hormone testosterone into estrogen. Also, at a high dose, it involves in phosphodiesterase inhibition. This leads to an elevation in the level of testosterone steroidogenesis in Leydig cells [109].

3. Conclusion

The use of herbal plants for medicinal purposes has been passed down through generations all over the world due to their positive results with minimal side effects and will continue to be used in the future. The main paradigm shift here is that all segments of society cannot afford the costs of synthetic products and surgical treatments. Besides, the success rate is comparatively low, with greater side effects. Moreover, the artificial insemination of hormones is risky and has degraded the quality of life. On the contrary, naturopathic treatment is more cost-effective, has increased bioavailability, has few or no side effects, and has a high success rate. Hence, the switch from synthetic medicines to herbal formulations has been recognized. However, clinical studies and research on medicinal plants should be continued so as to outweigh the use of synthetic products, thereby improving the quality of life. This article comprises various phytochemicals that enhance the fertility rate as well as treat other conditions that are associated with infertility.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare no conflict of interest.

Authors’ Contributions

Saziini H Chorosho and Neha Malik contributed to the data curation, investigation, and methodology. Gulsheen Panesar and Pratima Kumari contributed to the writing of the original draft. Sarita Jangra and Rupinder Kaur were responsible for the validation and review. Mariam S. Al-Ghamdi and Tasahil S. Albishi were responsible for the final manuscript draft. Hitesh Chopra and Ravinder Singh were responsible for the conceptualization and for reviewing. H.C. Ananda Murthy contributed to the supervision and final reviewing and editing.

References

World Health Organisation, “Factsheet,” 2020, https://www.who.int/news-room/fact-sheets/detail/infertility.
View at: Google Scholar
S. Saha, P. Roy, C. Corbitt, and S. S. Kakar, “Application of stem cell therapy for infertility,” Cell, vol. 10, no. 7, p. 1613, 2021.
View at: Publisher Site | Google Scholar
D. Bhartiya, I. Hinduja, H. Patel, and R. Bhilawadikar, “Making gametes from pluripotent stem cells–a promising role for very small embryonic-like stem cells,” Reproductive Biology and Endocrinology, vol. 12, no. 1, p. 114, 2014.
View at: Publisher Site | Google Scholar
A. Ferlin, F. Raicu, V. Gatta, D. Zuccarello, G. Palka, and C. Foresta, “Male infertility: role of genetic background,” Reproductive Biomedicine Online, vol. 14, no. 6, pp. 734–745, 2007.
View at: Publisher Site | Google Scholar
K. L. O'Flynn O'Brien, A. C. Varghese, and A. Agarwal, “The genetic causes of male factor infertility: a review,” Fertility and Sterility, vol. 93, no. 1, pp. 1–12, 2010.
View at: Publisher Site | Google Scholar
T. Behl, K. Kumar, C. Brisc et al., “Exploring the multifocal role of phytochemicals as immunomodulators,” Biomedicine & Pharmacotherapy, vol. 133, article 110959, 2021.
View at: Publisher Site | Google Scholar
R. K. Sindhu, S. Prabhjot Kaur, P. K. Manshu, A. Goyal, R. Bala, and A. Sandhu, “Phytochemicals: extraction, isolation methods, identification and therapeutic uses: a review,” Plant Archives, vol. 21, Supplement 1, pp. 174–184, 2021.
View at: Publisher Site | Google Scholar
B. V. Rossi, M. Abusief, and S. A. Missmer, “Modifiable risk factors and infertility: what are the connections?” American Journal of Lifestyle Medicine, vol. 10, no. 4, pp. 220–231, 2016.
View at: Publisher Site | Google Scholar
S. Esfandyari, R. M. Chugh, H.-s. Park, E. Hobeika, M. Ulin, and A. Al-Hendy, “Mesenchymal stem cells as a bio organ for treatment of female infertility,” Cell, vol. 9, no. 10, p. 2253, 2020.
View at: Publisher Site | Google Scholar
W. C. Dodson and A. F. Haney, “Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility,” Fertility and Sterility, vol. 55, no. 3, pp. 457–467, 1991.
View at: Publisher Site | Google Scholar
K. L. Rooney and A. D. Domar, “The relationship between stress and infertility,” Dialogues in Clinical Neuroscience, vol. 20, no. 1, pp. 41–47, 2018.
View at: Publisher Site | Google Scholar
C. S. Sullivan-Pyke, S. Senapati, M. A. Mainigi, and K. T. Barnhart, “In vitro fertilization and adverse obstetric and perinatal outcomes,” Seminars in Perinatology, vol. 41, no. 6, pp. 345–353, 2017.
View at: Publisher Site | Google Scholar
M. A. Asmabi and M. K. Jithesh, “Ayurveda management of infertility associated with poly cystic ovarian syndrome: a case report,” Journal of Ayurveda and Integrative Medicine, vol. 13, no. 2, article 100513, 2022.
View at: Publisher Site | Google Scholar
M. Akbaribazm, N. Goodarzi, and M. Rahimi, “Female infertility and herbal medicine: an overview of the new findings,” Food Science & Nutrition, vol. 9, no. 10, pp. 5869–5882, 2021.
View at: Publisher Site | Google Scholar
R. K. Singla, X. He, H. Chopra et al., “Natural products for the prevention and control of the COVID-19 pandemic: sustainable bioresources,” Frontiers in Pharmacology, vol. 12, article 758159, 2021.
View at: Publisher Site | Google Scholar
T. Bhattacharya, G. A. Borges, E. Soares et al., “Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders,” Materials, vol. 15, no. 3, p. 804, 2022.
View at: Publisher Site | Google Scholar
R. K. Singla, C. S. Sai, H. Chopra et al., “Natural products for the management of castration-resistant prostate cancer: special focus on nanoparticles based studies,” Frontiers in Cell and Developmental Biology, vol. 9, article 745177, 2021.
View at: Publisher Site | Google Scholar
H. Chopra, P. S. Dey, D. Das et al., “Curcumin nanoparticles as promising therapeutic agents for drug targets,” Molecules, vol. 26, no. 16, p. 4998, 2021.
View at: Publisher Site | Google Scholar
A. Yüce, G. Türk, S. Çeribaşi, M. Sönmez, M. Çiftçi, and M. Güvenç, “Effects of cinnamon (Cinnamomum zeylanicum) bark oil on testicular antioxidant values, apoptotic germ cell and sperm quality,” Andrologia, vol. 45, no. 4, pp. 248–255, 2013.
View at: Publisher Site | Google Scholar
Z. Esmaeilinezhad, S. Babajafari, Z. Sohrabi, M.-H. Eskandari, S. Amooee, and R. Barati-Boldaji, “Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: a randomized, triple blind, controlled trial,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 29, no. 2, pp. 201–208, 2019.
View at: Publisher Site | Google Scholar
K. Hossein, K. Leila, T. Ebrahim et al., “The effect of pomegranate juice extract on hormonal changes of female Wistar rats caused by polycystic ovarian syndrome,” Biomedical and Pharmacology Journal, vol. 8, no. 2, pp. 971–977, 2015.
View at: Publisher Site | Google Scholar
S. Sreeja, T. R. Santhosh Kumar, B. S. Lakshmi, and S. Sreeja, “Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation,” The Journal of Nutritional Biochemistry, vol. 23, no. 7, pp. 725–732, 2012.
View at: Publisher Site | Google Scholar
A. Saiyed, N. Jahan, S. A. A. Makbul, M. Ansari, H. Bano, and S. H. Habib, “Effect of combination of Withania somnifera Dunal and Tribulus terrestris Linn on letrozole induced polycystic ovarian syndrome in rats,” Integrative Medicine Research, vol. 5, no. 4, pp. 293–300, 2016.
View at: Publisher Site | Google Scholar
J. P. Bhattarai, S. A. Park, and S. K. Han, “The methanolic extract of Withania somnifera ACTS on GABAA receptors in gonadotropin releasing hormone (GnRH) neurons in mice,” Phytotherapy Research, vol. 24, no. 8, pp. 1147–1150, 2010.
View at: Publisher Site | Google Scholar
M. Kabiri, M. Kamalinejad, S. Bioos, M. Shariat, and F. Sohrabvand, “Comparative study of the effects of chamomile (Matricaria chamomilla L.) and cabergoline on idiopathic hyperprolactinemia: a pilot randomized controlled trial,” Iranian Journal of Pharmaceutical Research: IJPR, vol. 18, no. 3, pp. 1612–1621, 2019.
View at: Publisher Site | Google Scholar
H. Shoorei, A. Khaki, N. Ainehchi et al., “Effects of Matricaria chamomilla extract on growth and maturation of isolated mouse ovarian follicles in a three-dimensional culture system,” Chinese Medical Journal, vol. 131, no. 2, pp. 218–225, 2018.
View at: Publisher Site | Google Scholar
A. S. Das, D. Das, M. Mukherjee, S. Mukherjee, and C. Mitra, “Phytoestrogenic effects of black tea extract (Camellia sinensis) in an oophorectomized rat (Rattus norvegicus) model of osteoporosis,” Life Sciences, vol. 77, no. 24, pp. 3049–3057, 2005.
View at: Publisher Site | Google Scholar
A. E. Al-Snafi, S. H. Khorsheed, and A. H. Farj, “Mammary gland stimulating effects of the crude phenolic extracts of green tea (Camellia sinensis),” International Journal of Biological & Pharmaceutical Research, vol. 6, no. 7, pp. 573–576, 2015.
View at: Google Scholar
S. E. Khodarahmi, A. Eidi, and P. Mortazavi, “Effect of green tea extract (Camellia sinensis) on levels of sex hormones in letrozole-induced polycystic ovary syndrome (PCOS) in adult female Wistar rats,” Journal of Animal Physiology and Development, vol. 13, pp. 51–59, 2020.
View at: Google Scholar
M. Dokhanchi, H. K. Jashni, N. Tanideh, and N. Azarpira, “Effects of heart of palm (Palmito) extract on reproductive system of adult male rats,” Reproduction, vol. 2, no. 4, pp. 272–276, 2013.
View at: Publisher Site | Google Scholar
R. Rahimi and M. R. S. Ardekani, “Medicinal properties of Foeniculum vulgare Mill. in traditional Iranian medicine and modern phytotherapy,” Chinese Journal of Integrative Medicine, vol. 19, no. 1, pp. 73–79, 2013.
View at: Publisher Site | Google Scholar
M. Albert-Puleo, “Fennel and anise as estrogenic agents,” Journal of Ethnopharmacology, vol. 2, no. 4, pp. 337–344, 1980.
View at: Publisher Site | Google Scholar
S. Khani, M. Abdollahi, A. Khalaj, H. Heidari, and S. Zohali, “The effect of hydroalcoholic extract of Nigella sativa seed on dehydroepiandrosterone-induced polycystic ovarian syndrome in rats: an experimental study,” International Journal of Reproductive BioMedicine, vol. 19, no. 3, pp. 271–282, 2021.
View at: Publisher Site | Google Scholar
F. Eini, K. Joharchi, M. A. Kutenaei, and P. Mousavi, “Improvement in the epigenetic modification and development competence in PCOS mice oocytes by hydro-alcoholic extract of Nigella sativa during in-vitro maturation: an experimental study,” Biomedicine, vol. 18, no. 9, p. 733, 2020.
View at: Publisher Site | Google Scholar
M. Shamsi, V. Nejati, G. Najafi, and S. K. Pour, “Protective effects of licorice extract on ovarian morphology, oocyte maturation, and embryo development in PCOS-induced mice: an experimental study,” International Journal of Reproductive Biomedicine, vol. 18, no. 10, pp. 865–876, 2020.
View at: Publisher Site | Google Scholar
B. N. Jahromi, F. Farrokhnia, N. Tanideh, P. V. Kumar, M. E. Parsanezhad, and S. Alaee, “Comparing the effects of Glycyrrhiza glabra root extract, a cyclooxygenase-2 inhibitor (celecoxib) and a gonadotropin-releasing hormone analog (diphereline) in a rat model of endometriosis,” International Journal of Fertility & Sterility, vol. 13, no. 1, p. 45, 2019.
View at: Google Scholar
S. O. Abarikwu, C. L. Onuah, and S. K. Singh, “Plants in the management of male infertility,” Andrologia, vol. 52, no. 3, article e13509, 2020.
View at: Publisher Site | Google Scholar
A. S. Jalali and S. Hasanzadeh, “Crataegus monogyna fruit aqueous extract as a protective agent against doxorubicin-induced reproductive toxicity in male rats,” Avicenna Journal of Phytomedicine, vol. 3, no. 2, p. 159, 2013.
View at: Google Scholar
N. Jaradat and A. N. Zaid, “Herbal remedies used for the treatment of infertility in males and females by traditional healers in the rural areas of the West Bank/Palestine,” BMC Complementary and Alternative Medicine, vol. 19, no. 1, pp. 1–12, 2019.
View at: Publisher Site | Google Scholar
A. Shamsa, H. Hosseinzadeh, M. Molaei, M. T. Shakeri, and O. Rajabi, “Evaluation of Crocus sativus L. (saffron) on male erectile dysfunction: a pilot study,” Phytomedicine, vol. 16, no. 8, pp. 690–693, 2009.
View at: Publisher Site | Google Scholar
M. Mokhtari, E. Sharifi, and A. Daneshi, “Effects of hydro-alcoholic extract of red dried stigmas of Crocus sativus L. flowers (saffron) on the levels of pituitary-ovary hormones and folliculogenesis in rats,” International Journal of Fertility and Sterility, pp. 185–190, 2010.
View at: Google Scholar
M. Kolahdooz, S. Nasri, S. Zadeh Modarres, S. Kianbakht, and H. Fallah Huseini, “Effects of Nigella sativa L. seed oil on abnormal semen quality in infertile men: a randomized, double-blind, placebo-controlled clinical trial,” Phytomedicine, vol. 21, no. 6, pp. 901–905, 2014.
View at: Publisher Site | Google Scholar
M. Shirani, S. Shabanian, and M. Yavangi, “A systematic review of Iranian medicinal plants effective on female infertility,” Journal of Global Pharma Technology, vol. 10, no. 8, pp. 44–49, 2016.
View at: Google Scholar
M. M. Marbat, M. A. Ali, and A. M. Hadi, “The use of Nigella sativa as a single agent in treatment of male infertility,” Tikrit Journal of Pharmaceutical Sciences, vol. 9, no. 1, pp. 19–29, 2013.
View at: Google Scholar
E. N. Ozioko, G. A. Ajibade, and P. A. Vantsawa, “Fertility potentials of five medicinal plants in the treatment of infertility caused by polycystic ovarian syndrome in female Wistar albino rats,” International Journal of Complementary & Alternative Medicine, vol. 15, no. 4, pp. 213–218, 2022.
View at: Publisher Site | Google Scholar
S. Noh, A. Go, D. B. Kim, M. Park, H. W. Jeon, and B. Kim, “Role of antioxidant natural products in management of infertility: a review of their medicinal potential,” Antioxidants, vol. 9, no. 10, p. 957, 2020.
View at: Publisher Site | Google Scholar
A. Swaroop, A. S. Jaipuriar, S. K. Gupta et al., “Efficacy of a novel fenugreek seed extract (Trigonella foenum-graecum, FurocystTM) in polycystic ovary syndrome (PCOS),” International Journal of Medical Sciences, vol. 12, no. 10, pp. 825–831, 2015.
View at: Publisher Site | Google Scholar
M. Slighoua, I. Mahdi, F. Di Cristo et al., “Assessment of in vivo estrogenic and anti-inflammatory activities of the hydro-ethanolic extract and polyphenolic fraction of parsley (Petroselinum sativum Hoffm.),” Journal of Ethnopharmacology, vol. 265, article 113290, 2021.
View at: Publisher Site | Google Scholar
N. A. Khoramie, “The effects of essential oil of Lavandula angustifolia on sperm parameters quality and reproductive hormones in rats exposed to cadmium,” Journal of Reports in Pharmaceutical Sciences, vol. 4, no. 2, pp. 121–128, 2015.
View at: Google Scholar
M. Slighoua, I. Mahdi, F. E. Z. Amrati et al., “Ethnopharmacological survey of medicinal plants used in the traditional treatment of female infertility in Fez region, Morocco,” Phytothérapie, vol. 18, no. 5, pp. 321–339, 2020.
View at: Publisher Site | Google Scholar
N. Roozbeh, S. Rostami, and F. Abdi, “A review on herbal medicine with fertility and infertility characteristics in males,” The Iranian Journal of Obstetrics, Gynecology and Infertility, vol. 19, pp. 18–32, 2016.
View at: Google Scholar
J. G. Ghalehkandi, “Garlic (Allium sativum) juice protects from semen oxidative stress in male rats exposed to chromium chloride,” Animal Reproduction, vol. 11, no. 4, pp. 526–532, 2018.
View at: Google Scholar
H. Musavi, M. Tabnak, F. A. Sheini, M. H. Bezvan, F. Amidi, and M. Abbasi, “Effect of garlic (Allium sativum) on male fertility: a systematic review,” Pharmacology, vol. 7, no. 4, pp. 306–312, 2018.
View at: Publisher Site | Google Scholar
M. M. Mbaye, B. El Khalfi, S. Ouzamode, B. Saadani, N. Louanjli, and A. Soukri, “Effect of Origanum vulgare essential oil supplementation on the advanced parameters of mobility and on the integrity of human sperm DNA,” International Journal of Reproductive Medicine, vol. 2020, Article ID 1230274, 8 pages, 2020.
View at: Publisher Site | Google Scholar
A. Ghorbani Ranjbary, N. Ghorbani Ranjbary, Z. Ghorbani Ranjbary, and F. Jouibar, “Effects of intraperitoneal injection of extracts of Origanum vulgare on gonadotropin and testosterone hormones in male Wistar rats,” Journal of Babol University of Medical Sciences, vol. 16, no. 4, pp. 57–63, 2014.
View at: Google Scholar
S. R. Kopalli, S.-Y. Hwang, Y.-J. Won et al., “Korean red ginseng extract rejuvenates testicular ineffectiveness and sperm maturation process in aged rats by regulating redox proteins and oxidative defense mechanisms,” Experimental Gerontology, vol. 69, pp. 94–102, 2015.
View at: Publisher Site | Google Scholar
S. Dutta and P. Sengupta, “Medicinal herbs in the management of male infertility,” Journal of Pregnancy and Reproduction, vol. 2, no. 1, pp. 1–6, 2018.
View at: Publisher Site | Google Scholar
R. M. Salgado, M. H. Marques-Silva, E. Gonçalves, A. C. Mathias, J. G. Aguiar, and P. Wolff, “Effect of oral administration of Tribulus terrestris extract on semen quality and body fat index of infertile men,” Andrologia, vol. 49, no. 5, article e12655, 2017.
View at: Publisher Site | Google Scholar
R. Kenjale, R. Shah, and S. Sathaye, “Effects of Chlorophytum borivilianum on sexual behaviour and sperm count in male rats,” Phytotherapy Research, vol. 22, no. 6, pp. 796–801, 2008.
View at: Publisher Site | Google Scholar
S. K. Rath and A. K. Panja, “Clinical evaluation of root tubers of Shweta Musali (Chlorophytum borivilianum L.) and its effect on semen and testosterone,” AYU (An International Quarterly Journal of Research in Ayurveda), vol. 34, no. 3, pp. 273–275, 2013.
View at: Publisher Site | Google Scholar
K. K. Shukla, A. A. Mahdi, M. K. Ahmad, S. P. Jaiswar, S. N. Shankwar, and S. C. Tiwari, “Mucuna pruriens reduces stress and improves the quality of semen in infertile men,” Evidence-based Complementary and Alternative Medicine, vol. 7, no. 1, 2010.
View at: Publisher Site | Google Scholar
M. E. N. G. Hao-Cong, W. A. N. G. Shuo, L. I. Ying, Y.-Y. Kuang, and M. A. Chao-Mei, “Chemical constituents and pharmacologic actions of Cynomorium plants,” Chinese Journal of Natural Medicines, vol. 11, no. 4, pp. 321–329, 2013.
View at: Publisher Site | Google Scholar
C. Tocharus, R. Jeenapongsa, T. Teakthong, and Y. Smitasiri, “Effects of long-term treatment of Butea superba on sperm motility,” Naresuan University Journal: Science and Technology (NUJST), vol. 13, no. 2, pp. 11–17, 2013.
View at: Google Scholar
A. Manosroi, K. Sanphet, S. Saowakon, S. Aritajat, and J. Manosroi, “Effects of Butea superba on reproductive systems of rats,” Fitoterapia, vol. 77, no. 6, pp. 435–438, 2006.
View at: Publisher Site | Google Scholar
S. O. Oladimeji, J. O. Igbalaye, and C. L. Coleshowers, “Immunological biomarkers determined in female rats administered with pro-fertility extract of Anthocleista vogelii,” Journal of Natural Sciences Research, vol. 4, no. 8, pp. 113–123, 2014.
View at: Google Scholar
G. T. Mbemya, L. A. Vieira, F. G. Canafistula, O. D. L. Pessoa, and A. P. R. Rodrigues, “Relatos sobre a contribuiçao in vivo e in vitro de plantas medicinais na melhora da fun çao reprodutiva feminina,” Reprodução & Climatério, vol. 32, no. 2, pp. 109–119, 2017.
View at: Publisher Site | Google Scholar
I. A. H. Barakat, W. K. B. Khalil, and A. R. Al-Himaidi, “Moringa oleifera extract modulates the expression of fertility related genes and elevation of calcium ions in sheep oocytes,” Small Ruminant Research, vol. 130, pp. 67–75, 2015.
View at: Publisher Site | Google Scholar
L. A. Cajuday and G. L. Pocsidio, “Effects of Moringa oleifera Lam.(Moringaceae) on the reproduction of male mice (Mus musculus),” Journal of Medicinal Plants Research, vol. 4, no. 12, pp. 1115–1121, 2010.
View at: Google Scholar
L. Qian, W. Wang, J. Song, and D. Chen, “Peach gum polysaccharides improve the spermatogenesis of KKAy mice with impaired reproduction system,” American Journal of Reproductive Immunology, vol. 77, no. 3, article e12627, 2017.
View at: Publisher Site | Google Scholar
A. Ahangarpour, A. A. Oroojan, H. Heidari, E. Ghaedi, and R. Taherkhani, “Effects of hydro-alcoholic extract from Arctium lappa L. (Burdock) root on gonadotropins, testosterone, and sperm count and viability in male mice with nicotinamide/ streptozotocin-induced type 2 diabetes,” The Malaysian Journal of Medical Sciences, vol. 22, no. 2, pp. 25–32, 2015.
View at: Google Scholar
A. Akour, V. Kasabri, F. U. Afifi, and N. Bulatova, “The use of medicinal herbs in gynecological and pregnancy-related disorders by Jordanian women: a review of folkloric practice vs. evidence-based pharmacology,” Pharmaceutical Biology, vol. 54, no. 9, pp. 1901–1918, 2016.
View at: Publisher Site | Google Scholar
B. Fehri, K. K. M. Ahmed, and J.-M. Aiache, “Active spermatogenesis induced by a reiterated administration of Globularia alypum L. aqueous leaf extract,” Pharmacognosy Research, vol. 4, no. 3, pp. 138–147, 2012.
View at: Publisher Site | Google Scholar
H. Bordbar, T. Esmaeilpour, F. Dehghani, and M. R. Panjehshahin, “Stereological study of the effect of ginger's alcoholic extract on the testis in busulfan-induced infertility in rats,” Iranian Journal of Reproductive Medicine, vol. 11, no. 6, pp. 467–472, 2013.
View at: Google Scholar
C. Wang, Y. Jin, and Y. Jin, “Promoting effect of licorice extract on spermatogonial proliferation and spermatocytes differentiation of neonatal mice in vitro,” In Vitro Cellular & Developmental Biology-Animal, vol. 52, no. 2, pp. 149–155, 2016.
View at: Publisher Site | Google Scholar
M.-S. Chang, W.-N. Kim, W.-M. Yang, H.-Y. Kim, O. Ji-Hoon, and S.-K. Park, “Cytoprotective effects of Morinda officinalis against hydrogen peroxide-induced oxidative stress in Leydig TM3 cells,” Asian Journal of Andrology, vol. 10, no. 4, pp. 667–674, 2008.
View at: Publisher Site | Google Scholar
H. J. Chung, Y. Noh, M. S. Kim, A. Jang, C. E. Lee, and S. C. Myung, “Steroidogenic effects of Taraxacum officinale extract on the levels of steroidogenic enzymes in mouse Leydig cells,” Animal Cells and Systems, vol. 22, no. 6, pp. 407–414, 2018.
View at: Publisher Site | Google Scholar
A. Ilfergane and R. R. Henkel, “Effect of Typha capensis (Rohrb.)N.E.Br. rhizome extract F1 fraction on cell viability, apoptosis induction and testosterone production in TM3-Leydig cells,” Andrologia, vol. 50, no. 2, article e12854, 2018.
View at: Publisher Site | Google Scholar
A. K. Elmotayam, W. M. Elnattat, G. A. Ali et al., “Assessment of Ferula hermonis Boiss fertility effects in immature female rats supported by quantification of ferutinin via HPLC and molecular docking,” Journal of Ethnopharmacology, vol. 289, article 115062, 2022.
View at: Publisher Site | Google Scholar
P. B. Telefo, S. R. Tagne, O. E. S. Koona, D. M. Yemele, and F. M. Tchouanguep, “Effect of the aqueous extract of Justicia insularis T. Anders (Acanthaceae) on ovarian folliculogenesis and fertility of female rats,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 9, no. 2, pp. 197–203, 2012.
View at: Publisher Site | Google Scholar
R. Kono, S. Nomura, Y. Okuno et al., “3, 4-Dihydroxybenzaldehyde derived from Prunus mume seed inhibits oxidative stress and enhances estradiol secretion in human ovarian granulosa tumor cells,” Acta Histochemica et Cytochemica, vol. 47, no. 3, pp. 103–112, 2014.
View at: Publisher Site | Google Scholar
A. I. Ahmed, N. N. Lasheen, and K. M. El-Zawahry, “Ginkgo biloba ameliorates subfertility induced by testicular ischemia/reperfusion injury in adult Wistar rats: a possible new mitochondrial mechanism,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 6959274, 19 pages, 2016.
View at: Publisher Site | Google Scholar
N. A. Wahab, N. M. Mokhtar, W. N. Heriza, A. Halim, and S. Das, “The effect of Eurycoma Longifolia Jack on spermatogenesis in estrogen- treated rats,” Clinics, vol. 65, no. 1, pp. 93–98, 2010.
View at: Publisher Site | Google Scholar
A. P. Ebokaiwe, O. M. Ijomone, S. O. Osawe et al., “Alteration in sperm characteristics, endocrine balance and redox status in rats rendered diabetic by streptozotocin treatment: attenuating role of Loranthus micranthus,” Redox Report, vol. 23, no. 1, pp. 194–205, 2018.
View at: Publisher Site | Google Scholar
M. Sharma, D. Arya, K. Bhagour, and R. S. Gupta, “Modulatory effects of methanolic fruit fraction of Pedalium murex on sulphasalazine-induced male reproductive disruption,” Andrologia, vol. 51, no. 2, article e13190, 2019.
View at: Publisher Site | Google Scholar
L. L. Lienou, P. B. Telefo, J. R. Njimou et al., “Effect of the aqueous extract of Senecio biafrae (Oliv. & Hiern) J. Moore on some fertility parameters in immature female rat,” Journal of Ethnopharmacology, vol. 161, pp. 156–162, 2015.
View at: Publisher Site | Google Scholar
M. A. Mvondo, A. J. T. Sakock, S. B. Ateba, C. F. Awounfack, T. N. Gueyo, and D. Njamen, “Emmenagogue properties of Milicia excelsa (Welw.) C.C. Berg (Moraceae) based, at least in part, on its ability to correlate the activity of the hypothalamic-pituitary axis to that of the ovaries,” Journal of Ethnopharmacology, vol. 206, pp. 283–289, 2017.
View at: Publisher Site | Google Scholar
A. Tiwari, P. Singh, P. Jaitley et al., “Eucalyptus robusta leaves methanolic extract suppresses inflammatory mediators by specifically targeting TLR4/TLR9, MPO, COX2, iNOS and inflammatory cytokines in experimentally-induced endometritis in rats,” Journal of Ethnopharmacology, vol. 213, pp. 149–158, 2018.
View at: Publisher Site | Google Scholar
H.-J. Choi, T.-W. Chung, M.-J. Park et al., “Water-extracted tubers of Cyperus rotundus L. enhance endometrial receptivity through leukemia inhibitory factor-mediated expression of integrin αVβ3 and αVβ5,” Journal of Ethnopharmacology, vol. 208, pp. 16–23, 2017.
View at: Publisher Site | Google Scholar
A. Hardani, M. R. Afzalzadeh, A. Amirzargar, E. Mansouri, and Z. Meamar, “Effects of aqueous extract of celery (Apium graveolens L.) leaves on spermatogenesis in healthy male rats,” Avicenna Journal of Phytomedicine, vol. 5, no. 2, pp. 113–119, 2015.
View at: Google Scholar
S. Parhizkar, M. J. Yusoff, and M. A. Dollah, “Effect of Phaleria macrocarpa on sperm characteristics in adult rats,” Advanced Pharmaceutical Bulletin, vol. 3, no. 2, pp. 345–352, 2013.
View at: Publisher Site | Google Scholar
V. Sharma, J. Boonen, B. De Spiegeleer, and V. K. Dixit, “Androgenic and spermatogenic activity of alkylamide-rich ethanol solution extract of Anacyclus pyrethrum DC,” Phytotherapy Research, vol. 27, no. 1, pp. 99–106, 2013.
View at: Publisher Site | Google Scholar
R. Battaglia, A. Caponnetto, A. M. Caringella et al., “Resveratrol treatment induces Mito-miRNome modification in follicular fluid from aged women with a poor prognosis for in vitro fertilization cycles,” Antioxidants, vol. 11, no. 5, p. 1019, 2022.
View at: Publisher Site | Google Scholar
E. Illiano, F. Trama, A. Zucchi, R. G. Iannitti, B. Fioretti, and E. Costantini, “Resveratrol-based multivitamin supplement increases sperm concentration and motility in idiopathic male infertility: a pilot clinical study,” Clinical Medicine, vol. 9, no. 12, p. 4017, 2020.
View at: Publisher Site | Google Scholar
A. Ochiai and K. Kuroda, “Preconception resveratrol intake against infertility: friend or foe?” Reproductive Medicine and Biology, vol. 19, no. 2, pp. 107–113, 2020.
View at: Publisher Site | Google Scholar
J. Rudzitis-Auth, M. D. Menger, and M. W. Laschke, “Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis,” Human Reproduction, vol. 28, no. 5, pp. 1339–1347, 2013.
View at: Publisher Site | Google Scholar
A.-M. Dull, M. A. Moga, O. G. Dimienescu, G. Sechel, V. Burtea, and C. V. Anastasiu, “Therapeutic approaches of resveratrol on endometriosis via anti-inflammatory and anti-angiogenic pathways,” Molecules, vol. 24, no. 4, p. 667, 2019.
View at: Publisher Site | Google Scholar
I. Wocławek-Potocka, C. Mannelli, D. Boruszewska, I. Kowalczyk-Zieba, T. Waśniewski, and D. J. Skarżyński, “Diverse effects of phytoestrogens on the reproductive performance: cow as a model,” International Journal of Endocrinology, vol. 2013, Article ID 650984, 15 pages, 2013.
View at: Publisher Site | Google Scholar
A. Giwercman, “Estrogens and phytoestrogens in male infertility,” Current Opinion in Urology, vol. 21, no. 6, pp. 519–526, 2011.
View at: Publisher Site | Google Scholar
A. R. Cooper, “To eat soy or to not eat soy: the ongoing look at phytoestrogens and fertility,” Fertility and Sterility, vol. 112, no. 5, pp. 825-826, 2019.
View at: Publisher Site | Google Scholar
D. Desmawati and D. Sulastri, “Phytoestrogens and their health effect,” Open Access Macedonian Journal of Medical Sciences, vol. 7, no. 3, pp. 495–499, 2019.
View at: Publisher Site | Google Scholar
S. Nikbin, A. Derakhshideh, M. H. Tarighe et al., “Synergic effects of aerobic exercise and eugenol supplement on germ cell development and testicular tissue structure in chlorpyrifos-treated animal model,” Environmental Science and Pollution Research, vol. 27, no. 14, pp. 17229–17242, 2020.
View at: Publisher Site | Google Scholar
H. Helmy, N. A. H. Sadik, L. Badawy, and N. H. Sayed, “Mechanistic insights into the protective role of eugenol against stress- induced reproductive dysfunction in female rat model,” Chemico-Biological Interactions, vol. 367, article 110181, 2022.
View at: Publisher Site | Google Scholar
A. Balan, M. A. Moga, L. Dima et al., “An overview on the conservative management of endometriosis from a naturopathic perspective: phytochemicals and medicinal plants,” Plants, vol. 10, no. 3, p. 587, 2021.
View at: Publisher Site | Google Scholar
F. Peng, H. Yichuan, S. Peng, N. Zeng, and L. Shi, “Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis,” Annals of Medicine, vol. 54, no. 1, pp. 578–587, 2022.
View at: Publisher Site | Google Scholar
S. Park, W. Lim, F. W. Bazer, and G. Song, “Apigenin induces ROS-dependent apoptosis and ER stress in human endometriosis cells,” Journal of Cellular Physiology, vol. 233, no. 4, pp. 3055–3065, 2018.
View at: Publisher Site | Google Scholar
I. Viktorov, E. Bozadjieva, and M. Protich, “Pharmacological, pharmacokinetic, toxicological and clinical studies on protodioscin,” IIMS Therapeutic Focus, vol. 2, pp. 311–313, 1994.
View at: Google Scholar
K. M. Arsyad, “Result of protodioscin (Tribulus terrestris) treatment in males diagnosed with infertility and impotence,” Medicinal Biology Division Andrology, 1996.
View at: Google Scholar
I. A. Bhat, I. Ahmad, I. N. Mir et al., “Chitosan-eurycomanone nanoformulation acts on steroidogenesis pathway genes to increase the reproduction rate in fish,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 185, pp. 237–247, 2019.
View at: Publisher Site | Google Scholar
B.-S. Low, S.-B. Choi, H. A. Wahab, P. K. Das, and K.-L. Chan, “Eurycomanone, the major quassinoid in Eurycoma longifolia root extract increases spermatogenesis by inhibiting the activity of phosphodiesterase and aromatase in steroidogenesis,” Journal of Ethnopharmacology, vol. 149, no. 1, pp. 201–207, 2013.
View at: Publisher Site | Google Scholar
A. Talmor and B. Dunphy, “Female obesity and infertility,” Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 29, no. 4, pp. 498–506, 2015.
View at: Publisher Site | Google Scholar
M. L. Macer and H. S. Taylor, “Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility,” Clinics, vol. 39, no. 4, pp. 535–549, 2012.
View at: Publisher Site | Google Scholar
T. M. Gruber and S. Mechsner, “Pathogenesis of endometriosis: the origin of pain and subfertility,” Cell, vol. 10, no. 6, p. 1381, 2021.
View at: Publisher Site | Google Scholar
C. F. S. Jensen, P. Østergren, J. M. Dupree, D. A. Ohl, J. Sønksen, and M. Fode, “Varicocele and male infertility,” Nature Reviews Urology, vol. 14, no. 9, pp. 523–533, 2017.
View at: Publisher Site | Google Scholar
E. Barati, H. Nikzad, and M. Karimian, “Oxidative stress and male infertility: current knowledge of pathophysiology and role of antioxidant therapy in disease management,” Cellular and Molecular Life Sciences, vol. 77, no. 1, pp. 93–113, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Saziini H. Chorosho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1432

Downloads

716

Citations